Secular Trend of Hospital-Acquired Candidemia among Intensive Care Unit Patients in the United states during 1989–1999
作者： W. E. Trick , S. K. Fridkin , J. R. Edwards , R. A. Hajjeh , R. P. Gaynes
DOI: 10.1086/342300
关键词:
摘要: We describe the annual incidence of primary bloodstream infection (BSI) associated with Candida albicans and common non-albicans species among patients in intensive care units that participated National Nosocomial Infections Surveillance system from 1 January 1989 through 31 December 1999. During study period, there was a significant decrease C. BSI (P<.001) increase glabrata (P =.05).
oup.com
paperity.org
oxfordjournals.org
jstor.org 参考文章(20)
Yasmina F. Berrouane, Loreen A. Herwaldt, Michael A. Pfaller, Trends in Antifungal Use and Epidemiology of Nosocomial Yeast Infections in a University Hospital Journal of Clinical Microbiology. ,vol. 37, pp. 531- 537 ,(1999) , 10.1128/JCM.37.3.531-537.1999
Margarete Borg-von Zepelin, H. Eiffert, M. Kann, R. Rüchel, Changes in the spectrum of fungal isolates: results from clinical specimens gathered in 1987/88 compared with those in 1991/92 in the University Hospital Gottingen, Germany Mycoses. ,vol. 36, pp. 247- 253 ,(2009) , 10.1111/J.1439-0507.1993.TB00759.X
M. A. Pfaller, R. N. Jones, G. V. Doern, H. S. Sader, R. J. Hollis, S. A. Messer, for The Sentry Participant Group, International Surveillance of Bloodstream Infections Due to Candida Species: Frequency of Occurrence and Antifungal Susceptibilities of Isolates Collected in 1997 in the United States, Canada, and South America for the SENTRY Program Journal of Clinical Microbiology. ,vol. 36, pp. 1886- 1889 ,(1998) , 10.1128/JCM.36.7.1886-1889.1998
Chesley Richards, T Grace Emori, Jonathan Edwards, Scott Fridkin, James Tolson, Robert Gaynes, National Nosocomial Infections Surveillance (NNIS) System, Characteristics of hospitals and infection control professionals participating in the National Nosocomial Infections Surveillance System 1999. American Journal of Infection Control. ,vol. 29, pp. 400- 403 ,(2001) , 10.1067/MIC.2001.118408
Sergio B. Wey, Risk Factors for Hospital-Acquired Candidemia Archives of Internal Medicine. ,vol. 149, pp. 2349- 2353 ,(1989) , 10.1001/ARCHINTE.1989.00390100145030
Drew J. Winston, Anita Pakrasi, Ronald W. Busuttil, Prophylactic Fluconazole in Liver Transplant Recipients Annals of Internal Medicine. ,vol. 131, pp. 729- 737 ,(1999) , 10.7326/0003-4819-131-10-199911160-00003
Julia S. Garner, William R. Jarvis, T.Grace Emori, Teresa C. Horan, James M. Hughes, CDC definitions for nosocomial infections, 1988 American Journal of Infection Control. ,vol. 16, pp. 128- 140 ,(1988) , 10.1016/0196-6553(88)90053-3
Jose A. Vazquez, Grace Peng, Jack D. Sobel, Lynn Steele‐Moore, Paula Schuman, William Holloway, James D. Neaton, , Evolution of Antifungal Susceptibility among Candida Species Isolates Recovered from Human Immunodeficiency Virus—Infected Women Receiving Fluconazole Prophylaxis Clinical Infectious Diseases. ,vol. 33, pp. 1069- 1075 ,(2001) , 10.1086/322641
Walter T. Hughes, Donald Armstrong, Gerald P. Bodey, Arthur E. Brown, John E. Edwards, Ronald Feld, Philip Pizzo, Kenneth V. I. Rolston, Jerry L. Shenep, Lowell S. Young, 1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever Clinical Infectious Diseases. ,vol. 25, pp. 551- 573 ,(1997) , 10.1086/513764
Coleman Rotstein, Eric J. Bow, Michel Laverdiere, Stratis Ioannou, Danielle Carr, Narguess Moghaddam, , Randomized Placebo-Controlled Trial of Fluconazole Prophylaxis for Neutropenic Cancer Patients: Benefit Based on Purpose and Intensity of Cytotoxic Therapy Clinical Infectious Diseases. ,vol. 28, pp. 331- 340 ,(1999) , 10.1086/515128